Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...
In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Fulcrum Therapeutics (FULC – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback